Workflow
惠泰医疗: 第二届董事会第二十三次会议决议公告

Group 1 - The company held its 23rd meeting of the second board session on July 7, 2025, with 100% attendance from the board members [1] - The board approved a proposal to waive part of the preemptive rights and increase capital to a controlling subsidiary, which constitutes a related party investment and transaction [1][2] - The proposal to adjust the grant price and quantity of the 2021 restricted stock incentive plan was also approved, with 7 votes in favor and no opposition [2][3] Group 2 - The board approved a proposal to change the registered capital and amend the company's articles of association, with unanimous support from all board members [3] - The board agreed to convene the second extraordinary general meeting of shareholders in 2025, with details to be announced later [3]